Profil
Dr. Gregory S.
Wagner is Senior Vice President-Research & Development at Resverlogix Corp.
Dr. Wagner was previously employed as Vice President-PreClinical Development by Galileo Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Iowa, and a doctorate degree from the University of Iowa.
Ehemalige bekannte Positionen von Gregory S. Wagner
| Unternehmen | Position | Ende |
|---|---|---|
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01.01.2006 |
| RESVERLOGIX CORP. | Corporate Officer/Principal | - |
Ausbildung von Gregory S. Wagner
| University of Iowa | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
